kidney failure semaglutide Research shows — commonly sold as Ozempic or Wegovy — can improve function and survival rates for people with some chronic diseases, even if they have heart issues. ✍️ Health Patients with type 2 #diabetes

The Revolutionary Role of GLP-1 Agonists and SGLT-2 Inhibitors in Managing Diabetes and Chronic Kidney Disease Shankar Chakkera, Elizabeth J

Learn how to evaluate compounded GLP-1 clinical safety, identify potential risks, document patient care, and guide treatment decisions with confidence.

Dose Display

The FDA does not explicitly require a single fixed-dose maintenance strategy

Combination therapy with GLP-1 RAs was preferred for those with ongoing CKD progression and/or high cardiometabolic risk

The pharmaceutical manufacturers of semaglutide and tirzepatide initiated litigation to stop the production of compounded versions of these medications, and those lawsuits were recently dismissed